Dysregulation of Protein Phosphorylation/Dephosphorylation in Alzheimer's Disease: A Therapeutic Target
Studies during the last two decades have provided new insights into the molecular mechanism of Alzheimer's disease (AD). One of the milestone findings in AD research was the demonstration that neurofibrillary degeneration characterized by tau pathology is central to the pathogenesis of AD and o...
Main Authors: | Cheng-Xin Gong, Fei Liu, Inge Grundke-Iqbal, Khalid Iqbal |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2006-01-01
|
Series: | Journal of Biomedicine and Biotechnology |
Online Access: | http://dx.doi.org/10.1155/JBB/2006/31825 |
Similar Items
-
Memantine Attenuates Alzheimer's Disease-Like Pathology and Cognitive Impairment.
by: Xiaochuan Wang, et al.
Published: (2015-01-01) -
Therapeutic Strategies to Target Calcium Dysregulation in Alzheimer’s Disease
by: Maria Calvo-Rodriguez, et al.
Published: (2020-11-01) -
Studies on the phosphorylation and dephosphorylation of rhodopsin
by: Fowles, C.
Published: (1988) -
Phosphorylation and Dephosphorylation of Tau Protein During Synthetic Torpor
by: Marco Luppi, et al.
Published: (2019-06-01) -
Relevance of Phosphorylation and Truncation of Tau to the Etiopathogenesis of Alzheimer’s Disease
by: Yan Zhou, et al.
Published: (2018-02-01)